Cilostazol improves walking distance in intermittent claudication: Study Dr. Shravani Dali25 Sept 2021 10:30 AM ISTCilostazol may increase both the total distance and distance walked before the initiation of pain in patients suffering from intermittent...
Intas secures CDSCO panel nod to study arthritis drug Adalimumab Medical Dialogues Team24 Sept 2021 5:08 PM ISTNew Delhi: In a significant development, drug firm Intas has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Ampio Pharma wins DCGI nod to begin AP-019 study to treat Covid-linked respiratory distress Ruchika Sharma24 Sept 2021 12:00 PM ISTEnglewood: Ampio Pharmaceuticals, a biopharmaceutical company has recently announced regulatory approval from the Drugs Controller...
LifeCell gets DCGI approval for clinical trial of Mesocel to treat COVID patients Ruchika Sharma17 Sept 2021 4:25 PM ISTNew Delhi: Stem cell bank LifeCell on Thursday said it has received approval from the Drug Controller General of India (DCGI) for a clinical trial of...
Antiviral drug Umifenovir proves successful in clinical trials for COVID MD Bureau16 Sept 2021 10:00 AM ISTLucknow: The Central Drug Research Institute (CDRI) has claimed that the clinical trials of antiviral drug, Umifenovir, in treatment of Covid-19, have...
Reliance Life Sciences gets DCGI approval for COVID vaccine trial Ruchika Sharma4 Sept 2021 1:36 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Friday granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct...
DCGI nod to phase 2, 3 trials of Biological E Corbevax in children Medical Dialogues Team2 Sept 2021 12:31 PM ISTNew Delhi: The Drugs Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3...
Conduct phase 3 trial of Nafamostat Mesilatefor for marketing approval: CDSCO panel tells Cipla Medical Dialogues Team15 Aug 2021 11:30 AM ISTNew Delhi: Rejecting drug maker Cipla's proposal to market and manufacture Nafamostat Mesilate for injection at 50 mg/vial and 100mg/vial, the Subject...
For chronic neck pain, Chuna Manual therapy yields better results than usual care: JAMA Dr. Shravani Dali13 Aug 2021 9:00 AM ISTChuna manual therapy yields better results than usual care for patients with chronic non-specific neck pain, suggests a study published in the JAMA...
Center gets SC notice on PIL seeking disclosure of COVID vaccine trial data Farhat Nasim9 Aug 2021 9:30 AM ISTWhile hearing the plea, the bench referred to the problem of "vaccine hesitancy" in the country and asked advocate Prashant Bhushan, who was appearing...
Revise clinical trial protocol for Remdesivir powder for inhalation: CDSCO panel tells Lupin Medical Dialogues Team4 Aug 2021 4:00 PM ISTNew Delhi: In response to the drug maker Lupin's proposal to conduct a PhaseII/III Clinical Trial protocol for Remdesivir Powder for Inhalation,...
Hydrocortisone does not improve risk of death or bronchopulmonary dysplasia in preterm babies: JAMA Dr. Shravani Dali3 Aug 2021 10:00 AM ISTSystemic Hydrocortisone when initiated 7 to 14 days after birth in ventilator-dependent, very preterm infants do not significantly improve the...
